Physician profile
John David Bertrand
NPI 1538197470
$10,666.64
in general payments reported to CMS, 2019-2025
52 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $709 · 2021: $3,844 · 2022: $1,390 · 2023: $1,358 · 2024: $918 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,519.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $2,051.00 | 2019-2024 | Enplace |
| Lina Medical USA INC | $2,000.00 | 2021 | |
| Abbvie INC. | $1,413.39 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Sumitomo Pharma America, INC. | $510.40 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $467.62 | 2021-2025 | |
| Pfizer INC. | $438.85 | 2019-2024 | |
| Astellas Pharma US INC | $389.60 | 2022-2025 | Veozah |
| Organon LLC | $259.84 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $255.12 | 2019-2025 | Slynd |
| Myovant Sciences INC. | $240.86 | 2021-2022 | |
| Shield Therapeutics INC | $189.83 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $187.85 | 2019-2022 | |
| Millicent US INC | $178.99 | 2022-2025 | Intrarosa, Femring, Femlyv |
| Medtronic, INC. | $157.77 | 2022-2025 | Ligasure, V-Loc 180 |
| Bayer Healthcare Pharmaceuticals INC. | $138.60 | 2022-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $134.25 | 2019-2025 | Summit Doppler |
| Amgen INC. | $97.22 | 2019-2022 | |
| Meditrina | $97.13 | 2022-2025 | |
| Ethicon US, LLC | $85.20 | 2021-2025 | Enseal X1, Harmonic, Vistaseal |
| Hologic Sales and Service, LLC | $83.10 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Daiichi Sankyo INC. | $75.34 | 2019-2022 | |
| Innovation Technologies INC | $72.03 | 2023-2025 | Irrisept |
| Minerva Surgical, INC | $70.07 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $67.21 | 2024-2025 | |
| Smith+Nephew, INC. | $66.07 | 2023-2025 | Stravix, Stravix Pl |
| Agile Therapeutics, INC. | $65.20 | 2021 | |
| Sage Therapeutics, LLC | $58.89 | 2024-2025 | Zurzuvae |
| Integra Lifesciences Corporation | $54.39 | 2024 | Biodoptix, Biodfactor, Biofix |
| Idorsia Pharmaceuticals US INC | $49.65 | 2023 | Quviviq |
| Olympus America INC. | $48.43 | 2025 | Olympus |
| Lupin INC. | $47.45 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $45.95 | 2024-2025 | Exparel |
| Mylan Pharmaceuticals INC. | $45.70 | 2020-2022 | |
| Aspira Women'S Health INC | $44.00 | 2022 | |
| Acessa Health INC. | $42.40 | 2019-2021 | |
| Avion Pharmaceuticals | $41.84 | 2020-2023 | Balcoltra |
| Exact Sciences Corporation | $37.25 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $36.19 | 2022-2023 | Vivjoa |
| Kedrion Biopharma INC. | $34.88 | 2019 | |
| Avanos Medical | $30.05 | 2021 | |
| Davol INC. | $29.36 | 2020 | |
| Duchesnay USA Incorporated | $29.25 | 2019 | |
| Sanara Medtech INC. | $28.10 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.56 | 2019-2020 | |
| Axonics, INC. | $21.34 | 2023 | Bulkamid |
| Vertical Pharmaceuticals, LLC | $20.95 | 2019 | |
| Channel Medsystems, INC. | $19.14 | 2023 | |
| Convatec INC. | $17.18 | 2025 | |
| Supernus Pharmaceuticals, INC. | $15.81 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $14.72 | 2019 | |
| Allergan, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bertrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.